ConductScience.org, home

Paper39119424

Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device.

Ren E and 4 others. Cureus, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device. Papers, record 39119424. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39119424

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device.
PubMed
Journal
Cureus
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.73, provisional
iCite
Revised in PubMed
2024-08-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ren EEmily
2Ren WWeiping
3Collins ACAngela C
4Robinson AAndrew
5Vaidya RRahul

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131628729Ambient theatre temperature and cement setting time in total knee arthroplasty.ANZ J Surg2019https://conductscience.org/library/papers/31628729PubMed
238155732Antibiotic cement nails manufactured with threaded rods or cannulated intramedullary nails are better than those made with guidewires and do not debond.OTA Int2024https://conductscience.org/library/papers/38155732PubMed
337206489Chemotherapy May Obviate Prophylactic Femoral Nail Surgery for Multiple Myeloma Patients With High Mirels' Score Lesions and Impending Pathological Hip Fracture.Cureus2023https://conductscience.org/library/papers/37206489PubMed
411485895New insights into the role of nuclear factor-kappaB in cell growth regulation.Am J Pathol2001https://conductscience.org/library/papers/11485895PubMed
521507715Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.Lancet Oncol2011https://conductscience.org/library/papers/21507715PubMed
628089230Metastatic fractures of long limb bones.Orthop Traumatol Surg Res2017https://conductscience.org/library/papers/28089230PubMed
724291039The combination of proteasome inhibitors bortezomib and gambogic acid triggers synergistic cytotoxicity in vitro but not in vivo.Toxicol Lett2014https://conductscience.org/library/papers/24291039PubMed
827917682The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.Expert Opin Drug Discov2017https://conductscience.org/library/papers/27917682PubMed
934401932
A pituitary cup biopsy is more accurate than reamings for histological diagnosis of intramedullary lesions during nailing of impending and pathologic fractures: a retrospective matched cohort analysis.
Int Orthop2021https://conductscience.org/library/papers/34401932PubMed
1028556562Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels.J Biomed Mater Res B Appl Biomater2018https://conductscience.org/library/papers/28556562PubMed
1124781451Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site.J Oncol Pharm Pract2015https://conductscience.org/library/papers/24781451PubMed
1220435880Polymethylmethacrylate: properties and contemporary uses in orthopaedics.J Am Acad Orthop Surg2010https://conductscience.org/library/papers/20435880PubMed
1333361554A distinctive release profile of vancomycin and tobramycin from a new and injectable polymeric dicalcium phosphate dehydrate cement (P-DCPD).Biomed Mater2021https://conductscience.org/library/papers/33361554PubMed
1424433088Management of bone disease in multiple myeloma.Expert Rev Hematol2014https://conductscience.org/library/papers/24433088PubMed
1536518066Antibiotic Cement-Coated Interlocked Intramedullary Nails for the Treatment of Infected Nonunion After Intramedullary Nailing.J Orthop Trauma2023https://conductscience.org/library/papers/36518066PubMed
1623822887Targeting the ubiquitin-proteasome system for cancer therapy.Expert Opin Ther Targets2013https://conductscience.org/library/papers/23822887PubMed
1725683996Surgical treatment of pathological fractures occurring at the proximal femur.Yonsei Med J2015https://conductscience.org/library/papers/25683996PubMed
1827804017Is It Appropriate to Treat Sarcoma Metastases With Intramedullary Nailing?Clin Orthop Relat Res2017https://conductscience.org/library/papers/27804017PubMed
1928135373Elution Profiles of Two Methods of Antibiotic Tibial Nail Preparations.Orthopedics2017https://conductscience.org/library/papers/28135373PubMed
2019390905Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity.Clin Orthop Relat Res2009https://conductscience.org/library/papers/19390905PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40550922Comparative evaluation of treatment strategies for femoral metastases: endoprosthesis reconstruction versus intramedullary nailing.Eur J Orthop Surg Traumatol2025https://conductscience.org/library/papers/40550922PubMed
39695697Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.J Hematol Oncol2024https://conductscience.org/library/papers/39695697PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39119424

GET https://conductscience.org/api/papers/v1/39119424/references?page=2